
Formulary Search
You are here : Home > Formulary Search
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Search Results : Acid Suppression (Children) (Esomeprazole - Acid Suppression (Children))
Records returned : 9 (on 29 May 2025 at 11:33:59).
Return to search results for ' Acid Suppression (Children) '.
Show Icon and Status Keys Hide Icon and Status Keys
Icon Key
NFD1
Non formulary
NFD2
Not assessed for formulary status. Apply to APC / DTC before use.
CD
Controlled drug. Prescribing and/or storage requirements may apply
R
Restrictions apply

Safety Alert

Unlicensed - no UK marketing license in place
Un
Off-label use. Not licensed for this indication.
NHSE
Treatment commissioned by NHS England
CDF
Cancer Drugs Fund
ICB
Treatment commissioned by the ICB
Link to the NICE website

Low carbon device
Status Key
Red
Specialist ONLY drugs - treatment initiated and continued by specialist clinicians
Amber
Prescribing initiated and stabilised by specialist but has potential to transfer to primary care under a formal shared care agreement
Green
GPs (or non-medical prescribers in primary care) are able to take full responsibility for initiation and continuation of prescribing.
Green (see narrative)
GPs (or non-medical prescribers in primary care) are able to take full responsibility for initiation and continuation of prescribing.
Please refer to the narrative on the Drug Profile page where additional information may be conveyed as to the place in therapy or restrictions for use that have been locally agreed.
Non Formulary
Not recommended for use in any health setting across the Surrey Heartlands Integrated Care System
Blue
Prescribing initiated and stabilised by specialist but has potential to transfer to primary care WITHOUT a formal shared care agreement. Please note that in some circumstances a specialist may recommend that prescribing can be started in primary care.
See narrative
See narrative - may be applied in instances where a traffic light status has not yet been agreed but an entry to the formulary has been made to clarify interim arrangements.
Drug
Indication
Status
Restrictions/Comments
Formulary Status
Links
Indication :
Status :
Green (see narrative)
Formulations :
- Granules
Restrictions / Comments:
Important
Branded Nexium granules for children/infants with enteral feeding tubes (6Fr or larger). Off-label use in infants under 1 year.
Generic granules 3rd line in children/infants under 1 year without an NG tube. Refer to PPI algorithm for details.
Formulary Status :
Links :
Indication :
Status :
Green
Formulations :
- Capsules
Restrictions / Comments:
Important
Preferred
1st line option in children who are able to swallow capsules.
Most capsules can also be opened and mixed with water or fruit juice (licensed).
Formulary Status :
Links :
Indication :
Status :
Green (see narrative)
Formulations :
- Dispersible tablets
Restrictions / Comments:
Important
Mezzopram is the preferred brand - smaller granule size. Omeprazole MUPS is an alternative.
Disperse in water then mix with juice, apple sauce or yoghurt
Formulary Status :
Links :
Indication :
Status :
Blue
Formulations :
- Oral suspension
Restrictions / Comments:
Important
Only for children under 10kg and/or with a feeding tube less than 8Fr
Formulary Status :
Links :
Indication :
Status :
Red
Formulations :
- Powder
Restrictions / Comments:
Important
Aclomep powder - ASPH NICU only
Formulary Status :
Links :
Indication :
Status :
Non Formulary
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Green (see narrative)
Formulations :
- Capsules
Restrictions / Comments:
Important
2nd line treatment option in children who are able to swallow capsules.
Some capsules are licensed to be opened and have their contents mixed with water, apple/tomato juice or sprinkled on soft food (e.g. yoghurt, apple puree)
Formulary Status :
Links :
Indication :
Status :
Green (see narrative)
Formulations :
- Oro-dispersible
Restrictions / Comments:
Important
2nd line treatment option in children unable to swallow omeprazole or lansoprazole capsules.
Oro-dispersible tablets disperse in the mouth to release gastro-resistant granules. Lansoprazole is NOT absorbed sublingually. The gastro-resistant granules must be swallowed for the medicine to be effective. The FasTabsĀ® can also be administered in apple or orange juice.
Formulary Status :
Links :
Indication :
Status :
Amber
Restrictions / Comments:
Formulary Status :
Links :